Biologic therapies: what and when?

T cell activation: for full activation, T cells require interaction between the antigen‐specific T cell receptor and the antigenic peptide presented in the context of self major histocompatibility complex (MHC) by the antigen‐presenting cell. A “costimulatory” second signal is then required, delivered by the interaction between cluster of differentiation (CD)28 on the T cell with CD80/86 on the antigen‐presenting cell. Later, the T cell expresses CTLA4, which has higher affinity for CD80/86, and delivers a down‐regulatory signal, thereby “switching off” the immune response when the pathogen is cleared. Fusion proteins based on the CTLA4 structure have been developed to block the costimulatory pathway, for use in autoimmunity and transplant rejection (fig 4).
Biologic therapies: what and when?

Publication

Biologic therapies: what and when?. (2007) Sarah L Johnston. J Clin Pathol. 2007 Jan;60(1):8-17. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates cll CL1 ncbigene_synonym DCLK1 9201
Homo sapiens Primates cll CL1 ncbigene_synonym ADGRL1 22859
Homo sapiens Primates cll CLI ncbigene_synonym CLU 1191
Homo sapiens Primates cll C11 ncbigene_synonym AKR1C4 1109
Homo sapiens Primates cll C11 ncbigene_synonym GZMB 3002
Homo sapiens Primates cll C11 ncbigene_synonym POLR3K 51728
Homo sapiens Primates CD4 CD4 ncbigene_symbol CD4 920
Homo sapiens Primates CTLA4 CTLA4 ncbigene_symbol CTLA4 1493
Homo sapiens Primates CD28 CD28 ncbigene_symbol CD28 940
Homo sapiens Primates MHC MHC ncbigene_synonym HLA-C 3107
Homo sapiens Primates CD80 CD80 ncbigene_symbol CD80 941

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID